SomaLogic, Inc. - Class A Common Stock SLGC 深 沪
等待开盘 04-19 09:30:00 美东时间
2.10
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 2.10
- 总市值 3.97亿
- 52周最高 3.79
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.73
- 委 比 0.00%
- 总股本 1.89亿
- 历史最高 14.72
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.00
- 每 手 1
- 风险率 0.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Despite Hitting US$2.10, Standard BioTools Insiders Still Sold Too Soon
Despite the fact that Standard BioTools Inc.'s (NASDAQ:SLGC) value has dropped ...
01-12 20:54
SomaLogic Presents New Research at American Heart Association Scientific Sessions
BOULDER, Colo. (November 10, 2023) — SomaLogic (NASDAQ: SLGC), a leader in AI d...
2023-11-11 01:00
Recap: SomaLogic Q3 Earnings
SomaLogic (NASDAQ:SLGC) reported its Q3 earnings results on Wednesday, November...
2023-11-09 05:35
Earnings Outlook For SomaLogic
SomaLogic (NASDAQ:SLGC) is set to give its latest quarterly earnings report on ...
2023-11-07 23:02
SomaLogic Announces New SomaScan 11K Platform
Expanded menu gives researchers broadest coverage of the proteome for increased...
2023-11-01 09:00
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SLGC, APRN, FNCB
NEW YORK, Oct. 4, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2023-10-05 10:42
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Upgrades For Steel Dynamics Inc (NASDAQ:STLD), Citigroup upgraded the previous ...
2023-09-25 23:00
Canaccord Genuity Downgrades SomaLogic to Hold, Announces $2.5 Price Target
Canaccord Genuity analyst Kyle Mikson downgrades SomaLogic (NASDAQ:SLGC) from Buy to Hold and announces $2.5 price target.
2023-09-25 21:17
SomaLogic Analyst Ratings
What is the target price for SomaLogic (SLGC)? The latest price target for S...
2023-09-25 21:17
SomaLogic Q2 EPS $(0.13) Beats $(0.16) Estimate, Sales $20.47M Beat $19.82M Estimate
SomaLogic (NASDAQ:SLGC) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.16) by 18.75 percent. This is unchanged from the same period last year. The company reported
2023-08-15 04:07
